In this regard, we compared serum B2M levels with albuminuria, CysC levels, the CKD‐EPI (CKD Epidemiology Collaboration) creatinine‐based equations, and the creatinine‐CysC combined equation in these patients looking the prognostic power for death and CKD progression. The gene discussed is B2M; the disease is chronic kidney disease.